cysteine has been researched along with montelukast in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 23 (47.92) | 29.6817 |
2010's | 22 (45.83) | 24.3611 |
2020's | 3 (6.25) | 2.80 |
Authors | Studies |
---|---|
Reiss, TF; Shingo, S; Zhang, J | 1 |
Fregonese, L; Rossi, GA; Sabatini, F; Silvestri, M | 1 |
Crimi, N; Mastruzzo, C; Pagano, C; Palermo, F; Pistorio, MP; Prosperini, G; Vancheri, C | 1 |
Andersen, L; Bouchelouche, K; Bouchelouche, P; Horn, T; Nordling, J | 1 |
Chapman, KR; Ferreira, IM; Gutierrez, C; Jardim, JR; Sandrini, A; Zamel, N | 1 |
Bibi, H; Eliraz, A; Madar, Z; Offer, S; Shoseyov, D | 1 |
Banderet, LE; Cymerman, A; Fulco, CS; Kaminsky, D; Muza, SR | 1 |
Haggart, K; Lee, DK; Lipworth, BJ; Robb, FM | 1 |
Abe, M; Hayashi, Y; Katsuragi, T; Murai, A; Sakata, N; Tanaka, K | 1 |
Alinovi, R; Baraldi, E; Carraro, S; Corradi, M; Pasquale, MF; Zacchello, F; Zanconato, S | 1 |
Bonville, CA; Domachowske, JB; Rosenberg, HF | 1 |
Fireman, E; Kivity, S; Sade, K; Schwartz, Y | 1 |
Barnes, PJ; Bush, A; Kharitonov, SA; Lex, C; Nicholson, AG; Payne, DN; Wilson, NM; Zacharasiewicz, A | 1 |
Bulut, Y; Deveci, F; Ilhan, N; Muz, MH; Turgut, T; Yekeler, H | 1 |
Ferland, C; Langlois, A; Laviolette, M; Tremblay, GM | 1 |
Hisatome, I; Igawa, G; Igawa, O; Kaetsu, Y; Matsubara, K; Matsuura, T; Shigemasa, C; Sugihara, S; Yamamoto, Y | 1 |
Parker, D; Pavord, I; Rice, L; Woodcock, A | 1 |
Leff, AR; Meliton, AY; Munoz, NM | 1 |
Abe, M; Akitake, Y; Fukunaga, J; Hosokawa, M; Murai, A; Takahashi, M | 1 |
Bramanti, P; Caminiti, R; Cuzzocrea, S; Di Paola, R; Genovese, T; Mazzon, E; Muià, C; Rossi, A; Sautebin, L | 1 |
Akamatsu, K; Hirano, T; Ichikawa, T; Ichinose, M; Koarai, A; Matsunaga, K; Minakata, Y; Sugiura, H; Yanagisawa, S | 1 |
Klanderman, B; Lima, J; Sylvia, J; Tantisira, KG; Weiss, ST | 1 |
Ikeda, Y; Imbe, S; Iwanaga, T; Muraki, M; Sato, R; Tohda, Y; Yamagata, S | 1 |
Neves, JS; Radke, AL; Weller, PF | 1 |
Dakhama, A; Gelfand, EW; Han, J; Jia, Y; Okamoto, M; Shiraishi, Y; Takeda, K | 1 |
Hunter, JC; Jia, Y; Jimenez, J; Lieber, G; McLeod, RL | 1 |
Câmara, NO; Hiyane, MI; Landgraf, MA; Landgraf, RG; Pacheco-Silva, A; Silva, RC | 1 |
Bunga, S; Israel, E; Kazani, S; Sadeh, J; Wechsler, ME | 1 |
Ewert, R; Felix, SB; Gläser, S; Gustavus, B; Koch, B; Kunkel, G; Noga, O; Schäper, C | 1 |
Cai, BL; Fang, SH; Huang, XQ; Lu, YB; Wang, XX; Wei, EQ; Yu, SY; Zhang, WP; Zhang, XY | 1 |
Li, CC; Zhang, WX | 1 |
Niimi, A | 1 |
He, Y; Lei, Y; Liu, XJ; Luo, F; Su, Q; Tang, X; Tian, C; Whitsett, JA; Wu, Q | 1 |
Fuchimoto, Y; Ikeda, G; Kanehiro, A; Kataoka, M; Koga, H; Kurimoto, E; Miyahara, N; Taniguchi, A; Tanimoto, M; Tanimoto, Y; Waseda, K | 1 |
Kohno, S; Matsuse, H | 1 |
Chelakkot-Govindalayathila, AL; D'Alessandro-Gabazza, CN; Fujisawa, T; Gabazza, EC; Harada, E; Hosoki, K; Kainuma, K; Nagao, M; Roeen, Z; Toda, M | 1 |
Ahsan, F; Gupta, N; Patel, B | 1 |
Jou, I; Kang, SJ; Park, JS; Park, SM; Seo, MK; Woo, HG | 1 |
Brugha, R; Dickson, I; Eldridge, S; Griffiths, CJ; Grigg, J; Holloway, JW; Koh, L; Nwokoro, C; Pandya, H; Price, D; Rutterford, C; Sanak, M; Turner, S; Vulliamy, T | 1 |
Asae, KH; Koizumi, Y; Kojima, Y; Nagase, H; Ohta, K; Ro, S; Sugimoto, N; Ujino, M; Yamashita, N | 1 |
Ba, L; Du, J; Liu, F; Liu, R; Liu, S; Liu, Y; Xian, J; Yu, L; Zhang, J; Zhou, J | 1 |
Chen, Y; Deng, B; Guo, R; Jiang, J; Jing, Z; Shi, Z | 1 |
Arnaud, C; Arnol, N; Bäck, M; Belaïdi, E; Gautier-Veyret, E; Lévy, P; Pépin, JL; Perrin, M; Stanke-Labesque, F; Tamisier, R | 1 |
Araújo, AC; Haeggström, JZ; Tang, X | 1 |
Arakawa, M; Hasegawa, T; Hayashi, M; Kikuchi, T; Kimura, Y; Koya, T; Saito, A; Takeuchi, H; Tsukioka, K; Ueno, H; Watanabe, S | 1 |
Kim, KS; Liu, W; Prakash, A; Zhang, C; Zhu, N | 1 |
Al-Azzam, N; Elsalem, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
6 review(s) available for cysteine and montelukast
Article | Year |
---|---|
[Leukotriene and respiratory syncytial virus].
Topics: Acetates; Asthma; Bronchiolitis, Viral; Cyclopropanes; Cysteine; Humans; Infant; Infant, Newborn; Leukotriene Antagonists; Leukotrienes; Nasopharynx; Quinolines; Respiratory Syncytial Virus Infections; Risk Factors; Sulfides | 2013 |
Cough, asthma, and cysteinyl-leukotrienes.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Antitussive Agents; Asthma; Cough; Cyclopropanes; Cysteine; Glucocorticoids; Humans; Leukotriene Antagonists; Leukotrienes; Quinolines; Sputum; Sulfides | 2013 |
Leukotriene receptor antagonists pranlukast and montelukast for treating asthma.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Chromones; Cyclopropanes; Cysteine; Humans; Leukotriene Antagonists; Leukotrienes; Quinolines; Sulfides | 2014 |
Targeting cysteinyl-leukotrienes in abdominal aortic aneurysm.
Topics: Acetates; Aortic Aneurysm, Abdominal; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Blood Vessels; Cyclopropanes; Cysteine; Humans; Leukotriene Antagonists; Leukotrienes; Quinolines; Receptors, Leukotriene; Sulfides; Thrombosis | 2018 |
Leukotriene D
Topics: Acetates; Airway Remodeling; Animals; Anti-Asthmatic Agents; Asthma; Bronchial Hyperreactivity; Cyclopropanes; Cysteine; Gene Expression; Humans; Hypersensitivity; Indoles; Inflammation Mediators; Leukotriene Antagonists; Leukotriene D4; Leukotrienes; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Sulfides; Sulfonamides; Tosyl Compounds | 2020 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
11 trial(s) available for cysteine and montelukast
Article | Year |
---|---|
Inhibitory effect of a leukotriene receptor antagonist (montelukast) on neurokinin A-induced bronchoconstriction.
Topics: Acetates; Adult; Bronchoconstriction; Cross-Over Studies; Cyclopropanes; Cysteine; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Leukotriene D4; Leukotrienes; Male; Methacholine Chloride; Neurokinin A; Quinolines; Sulfides | 2003 |
Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Biomarkers; Breath Tests; Cross-Over Studies; Cyclopropanes; Cysteine; Double-Blind Method; Exhalation; Female; Forced Expiratory Volume; Humans; Hydrogen Peroxide; Inflammation Mediators; Leukotrienes; Male; Nitric Oxide; Peak Expiratory Flow Rate; Pneumonia; Quinolines; Severity of Illness Index; Sulfides | 2003 |
Cysteinyl leukotriene blockade does not prevent acute mountain sickness.
Topics: Acetates; Administration, Oral; Adult; Altitude Sickness; Analysis of Variance; Chromatography, High Pressure Liquid; Cross-Over Studies; Cyclopropanes; Cysteine; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Humans; Leukotriene Antagonists; Leukotrienes; Male; Prevalence; Quinolines; Severity of Illness Index; Statistics, Nonparametric; Sulfides; Treatment Outcome | 2004 |
Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma.
Topics: Acetates; Administration, Inhalation; Adult; Aspirin; Asthma; Confidence Intervals; Cross-Over Studies; Cyclopropanes; Cysteine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Leukotrienes; Lysine; Male; Middle Aged; Nasal Provocation Tests; Peak Expiratory Flow Rate; Quinolines; Reference Values; Reproducibility of Results; Spirometry; Sulfides | 2004 |
Effect of montelukast on basophil releasability in patients with asthma.
Topics: Acetates; Adult; Asthma; Basophils; Cyclopropanes; Cysteine; Female; Histamine; Humans; Immunologic Factors; Leukotriene Antagonists; Leukotrienes; Male; Quinolines; Sulfides | 2005 |
Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
Topics: Acetates; Adrenergic beta-Agonists; Adult; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchial Hyperreactivity; Cyclopropanes; Cysteine; Double-Blind Method; Drug Combinations; Female; Fluticasone; Fluticasone-Salmeterol Drug Combination; Forced Expiratory Volume; Histamine; Humans; Interleukin-8; Leukotriene Antagonists; Leukotrienes; Lung; Male; Quinolines; Spirometry; Sputum; Sulfides; Time Factors; Treatment Outcome; United Kingdom | 2007 |
Molecular mechanism of the additive effects of leukotriene modifier in asthmatic patients receiving steroid therapy.
Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Adult; Asthma; Chemokine CCL5; Chromones; Cyclopropanes; Cysteine; Cytokines; Drug Synergism; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Leukotrienes; Male; Middle Aged; Quinolines; Sulfides | 2009 |
5-lipoxygenase pharmacogenetics in asthma: overlap with Cys-leukotriene receptor antagonist loci.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Cysteine; Female; Forced Expiratory Volume; Genotype; Humans; Hydroxyurea; Leukotriene Antagonists; Lipoxygenase Inhibitors; Male; Middle Aged; Polymorphism, Single Nucleotide; Quinolines; Receptors, Leukotriene; Sulfides | 2009 |
Cysteinyl leukotriene antagonism inhibits bronchoconstriction in response to hypertonic saline inhalation in asthma.
Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Aged; Asthma; Bronchoconstriction; Cyclopropanes; Cysteine; Epidemiologic Methods; Female; Humans; Leukotriene Antagonists; Leukotrienes; Male; Middle Aged; Polymorphism, Genetic; Quinolines; Receptors, Leukotriene; Saline Solution, Hypertonic; Sulfides; Young Adult | 2011 |
Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis.
Topics: Acetates; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Asthma, Aspirin-Induced; Cell Count; Cyclopropanes; Cysteine; Eosinophils; Female; Humans; Leukotriene Antagonists; Leukotrienes; Male; Middle Aged; Nasal Lavage Fluid; Nasal Polyps; Neurokinin A; Quinolines; Substance P; Sulfides; Treatment Outcome | 2011 |
Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial.
Topics: Acetates; Anti-Asthmatic Agents; Appointments and Schedules; Arachidonate 5-Lipoxygenase; Asthma; Child, Preschool; Cyclopropanes; Cysteine; Drug Administration Schedule; Female; Genotype; Humans; Infant; Leukotrienes; Male; Quinolines; Respiratory Sounds; Sulfides; Treatment Outcome | 2014 |
31 other study(ies) available for cysteine and montelukast
Article | Year |
---|---|
Correlation of airway obstruction and patient-reported endpoints in clinical studies.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Asthmatic Agents; Asthma; Clinical Trials as Topic; Cyclopropanes; Cysteine; Endpoint Determination; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Leukotrienes; Male; Middle Aged; Peak Expiratory Flow Rate; Pulmonary Ventilation; Quinolines; Sulfides; Treatment Outcome | 2001 |
Cysteinyl leukotrienes induce human eosinophil locomotion and adhesion molecule expression via a CysLT1 receptor-mediated mechanism.
Topics: Acetates; Cell Adhesion Molecules; Cell Movement; Child; Cyclopropanes; Cysteine; Eosinophils; Humans; Leukotrienes; Quinolines; Sulfides | 2002 |
The cysteinyl-leukotriene D4 induces cytosolic Ca2+ elevation and contraction of the human detrusor muscle.
Topics: Acetates; Calcium; Cells, Cultured; Cyclopropanes; Cysteine; Cytosol; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Indoles; Leukotriene Antagonists; Leukotriene D4; Leukotrienes; Membrane Proteins; Muscle Contraction; Muscle, Smooth; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Sarcoplasmic Reticulum; Sulfides; Sulfonamides; Tosyl Compounds; Urinary Bladder | 2003 |
A leukotriene receptor antagonist modulates iNOS in the lung and in a leukotriene-free cell model.
Topics: Acetates; Allergens; Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Bronchoalveolar Lavage Fluid; Cell Line; Cyclopropanes; Cysteine; Cytokines; Dexamethasone; Epithelial Cells; Immunohistochemistry; Leukotriene Antagonists; Leukotrienes; Lung; Male; Models, Animal; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Quinolines; Rats; Rats, Inbred BN; Sulfides | 2003 |
Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
Topics: Acetates; Airway Resistance; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bile; Bronchoalveolar Lavage Fluid; Cyclopropanes; Cysteine; Hypersensitivity; In Vitro Techniques; Leukocyte Count; Leukotriene A4; Leukotriene Antagonists; Leukotrienes; Lung; Methylprednisolone; Quinolines; Rats; Rats, Inbred BN; Receptors, Leukotriene; Sulfides | 2005 |
Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction.
Topics: Acetates; Adolescent; Ammonia; Asthma, Exercise-Induced; Biomarkers; Breath Tests; Bronchoconstriction; Child; Cyclopropanes; Cysteine; Exhalation; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Leukotriene B4; Leukotrienes; Nitric Oxide; Quinolines; Respiratory Function Tests; Sulfides | 2005 |
Ribavirin and cysteinyl leukotriene-1 receptor blockade as treatment for severe bronchiolitis.
Topics: Acetates; Animals; Antiviral Agents; Bronchiolitis, Viral; Cyclopropanes; Cysteine; Disease Models, Animal; Drug Therapy, Combination; Humans; Leukotriene Antagonists; Leukotrienes; Lung; Mice; Mice, Inbred C57BL; Murine pneumonia virus; Pneumovirus Infections; Quinolines; Ribavirin; Sulfides; Treatment Outcome; Virus Replication | 2006 |
Exhaled breath condensate cysteinyl leukotrienes and airway remodeling in childhood asthma: a pilot study.
Topics: Acetates; Adolescent; Asthma; Basement Membrane; Bronchi; Child; Child, Preschool; Cyclopropanes; Cysteine; Exhalation; Female; Humans; Leukotrienes; Male; Pilot Projects; Quinolines; Sulfides | 2006 |
The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Topics: Acetates; Airway Obstruction; Animals; Anti-Asthmatic Agents; Asthma; Collagen; Cyclopropanes; Cysteine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Goblet Cells; Hyperplasia; Hypertrophy; Leukotriene Antagonists; Leukotrienes; Lung; Mice; Mice, Inbred BALB C; Mucus; Muscle, Smooth; Pulmonary Fibrosis; Quinolines; Receptors, Leukotriene; Respiratory Mucosa; Sulfides | 2006 |
Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism.
Topics: Acetates; Adult; Arachidonic Acids; Cell Movement; Cyclopropanes; Cysteine; Enzyme Activation; Eosinophils; Female; Humans; Indoles; Leukotriene Antagonists; Leukotrienes; Male; Matrix Metalloproteinase 9; Quinolines; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Sulfides; Urokinase-Type Plasminogen Activator | 2006 |
Role of cysteinyl leukotrienes in the proliferation and the migration of murine vascular smooth muscle cells in vivo and in vitro.
Topics: Acetates; Animals; Anti-Bacterial Agents; Calcimycin; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclopropanes; Cysteine; Femoral Artery; Leukotriene Antagonists; Leukotrienes; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Models, Animal; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neovascularization, Physiologic; Quinolines; Sulfides; Wound Healing | 2007 |
Blockade of avidity and focal clustering of beta 2-integrin by cysteinyl leukotriene antagonism attenuates eosinophil adhesion.
Topics: Acetates; Arachidonate 5-Lipoxygenase; Benzoquinones; CD11b Antigen; CD18 Antigens; Cell Adhesion; Cells, Cultured; Chemokine CCL11; Cyclopropanes; Cysteine; Eosinophils; Humans; Inflammation Mediators; Interleukin-5; Leukotriene Antagonists; Leukotriene B4; Leukotrienes; Lipoxygenase Inhibitors; Quinolines; Sulfides | 2007 |
Comparative study to elucidate the mechanism underlying the difference in airway hyperresponsiveness between two mouse strains.
Topics: Acetates; Administration, Inhalation; Animals; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Cyclopropanes; Cysteine; Eosinophils; Immunoglobulin G; Leukotriene Antagonists; Leukotrienes; Macrophages; Methacholine Chloride; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Ovalbumin; Quinolines; Receptors, Leukotriene; Respiratory Hypersensitivity; Species Specificity; Sulfides | 2007 |
Effects of zileuton and montelukast in mouse experimental spinal cord injury.
Topics: Acetates; Animals; Apoptosis; Arachidonate 5-Lipoxygenase; Cyclooxygenase 2; Cyclopropanes; Cysteine; Dinoprostone; Disease Models, Animal; Gene Expression Regulation; Hydroxyurea; Inflammation; Leukotrienes; Lipoxygenase Inhibitors; Male; Mice; Neutrophil Infiltration; Quinolines; Recovery of Function; Spinal Cord Injuries; Sulfides; Tumor Necrosis Factor-alpha | 2008 |
Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
Topics: Acetates; Administration, Inhalation; Animals; Asthma; Bronchial Hyperreactivity; Bronchoconstriction; Cyclopropanes; Cysteine; Disease Models, Animal; Guinea Pigs; Immunologic Factors; Leukotriene Antagonists; Leukotriene C4; Leukotriene D4; Leukotrienes; Lung; Male; Ovalbumin; Quinolines; Sulfides | 2009 |
Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules.
Topics: Acetates; Blotting, Western; Cell Separation; Cell-Free System; Cyclopropanes; Cysteine; Eosinophil Cationic Protein; Eosinophils; Flow Cytometry; Humans; Leukotriene Antagonists; Leukotrienes; Quinolines; Receptors, Leukotriene; Secretory Vesicles; Sulfides | 2010 |
Montelukast during primary infection prevents airway hyperresponsiveness and inflammation after reinfection with respiratory syncytial virus.
Topics: Acetates; Animals; Animals, Newborn; Anti-Asthmatic Agents; Bronchiolitis, Viral; Bronchoalveolar Lavage Fluid; Cyclopropanes; Cysteine; Disease Models, Animal; Inflammation; Interferon-gamma; Leukotriene Antagonists; Leukotrienes; Mice; Mice, Inbred BALB C; Quinolines; Recurrence; Respiratory Hypersensitivity; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Sulfides | 2010 |
Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat.
Topics: Acetates; Animals; Cyclopropanes; Cysteine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Histamine; Histamine H1 Antagonists, Non-Sedating; Hypersensitivity; In Vitro Techniques; Leukotriene Antagonists; Leukotriene D4; Leukotrienes; Loratadine; Male; Nasal Mucosa; Neutrophil Infiltration; Quinolines; Rats; Rats, Inbred BN; Rhinitis; Sulfides; Sus scrofa | 2010 |
Leukotrienes produced in allergic lung inflammation activate alveolar macrophages.
Topics: Acetates; Allergens; Animals; Asthma; Cyclopropanes; Cysteine; Disease Models, Animal; Klebsiella pneumoniae; Leukotriene Antagonists; Leukotriene C4; Leukotrienes; Lung; Macrophages, Alveolar; Male; Nitric Oxide; Ovalbumin; Phagocytosis; Pneumonia; Quinolines; Rats; Rats, Wistar; Receptors, IgG; Sulfides | 2010 |
[Effects of agonist and antagonist of cysteinyl leukotriene receptors on differentiation of rat glioma C6 cells].
Topics: Acetates; Animals; Cell Differentiation; Cell Line, Tumor; Colforsin; Cyclopropanes; Cysteine; Glioma; Leukotriene Antagonists; Leukotriene D4; Leukotrienes; Quinolines; Rats; Receptors, Leukotriene; Sulfides | 2011 |
Foxa2 regulates leukotrienes to inhibit Th2-mediated pulmonary inflammation.
Topics: Acetates; Animals; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Arachidonate 5-Lipoxygenase; Cyclopropanes; Cysteine; Disease Models, Animal; Eosinophils; Goblet Cells; Hepatocyte Nuclear Factor 3-beta; Inflammation Mediators; Leukotriene Antagonists; Leukotrienes; Metaplasia; Mice; Mice, Knockout; Mice, Transgenic; Pneumonia; Quinolines; Signal Transduction; Sulfides; Th2 Cells | 2013 |
Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
Topics: Acetates; Animals; Asthma; Bronchoalveolar Lavage Fluid; Chemokines; Cyclopropanes; Cysteine; Female; Leukotriene Antagonists; Leukotrienes; Lung; Mice; Mice, Inbred BALB C; Pneumonia; Pulmonary Emphysema; Quinolines; Receptors, Leukotriene; Sulfides; Tumor Necrosis Factor-alpha | 2014 |
Montelukast suppresses epithelial to mesenchymal transition of bronchial epithelial cells induced by eosinophils.
Topics: Acetates; Airway Remodeling; Asthma; Bronchi; Cell Line, Tumor; Coculture Techniques; Collagen Type I; Cyclopropanes; Cysteine; Eosinophils; Epithelial-Mesenchymal Transition; Humans; Leukotriene Antagonists; Leukotrienes; Phosphorylation; Quinolines; Respiratory Mucosa; Smad3 Protein; Sulfides; Transforming Growth Factor beta1; Vimentin | 2014 |
Aerosolized montelukast polymeric particles-an alternative to oral montelukast-alleviate symptoms of asthma in a rodent model.
Topics: Acetates; Aerosols; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Cyclopropanes; Cysteine; Disease Models, Animal; Inflammation; L-Lactate Dehydrogenase; Lactic Acid; Leukotrienes; Lung; Ovalbumin; Peroxidase; Polyesters; Polymers; Quinolines; Rats; Rats, Sprague-Dawley; Sulfides | 2014 |
Role of cysteinyl leukotriene signaling in a mouse model of noise-induced cochlear injury.
Topics: Acetates; Animals; Cochlea; Cyclopropanes; Cysteine; Disease Models, Animal; Gene Expression Profiling; Leukotriene Antagonists; Leukotrienes; Matrix Metalloproteinase 3; Mice; Noise; Quinolines; Receptors, Leukotriene; Signal Transduction; Sulfides; Wounds and Injuries | 2014 |
Leukotriene receptor antagonist attenuated airway inflammation and hyperresponsiveness in a double-stranded RNA-induced asthma exacerbation model.
Topics: Acetates; Alum Compounds; Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Cyclopropanes; Cysteine; Cytokines; Disease Models, Animal; Disease Progression; Eosinophils; Immunization; Inflammation Mediators; Leukotriene Antagonists; Leukotrienes; Male; Mice; Ovalbumin; Poly I-C; Quinolines; Respiratory Hypersensitivity; RNA, Double-Stranded; RNA, Viral; Sulfides | 2017 |
The role of cysteinyl leukotrienes and their receptors in refractory nasal polyps.
Topics: Acetates; Adult; Cyclopropanes; Cysteine; Cytokines; Enterotoxins; Female; Gene Expression Regulation; Humans; Leukotriene Antagonists; Leukotrienes; Male; Middle Aged; Nasal Polyps; Quinolines; Receptors, Leukotriene; Sinusitis; Sulfides | 2017 |
Cysteinyl leukotriene receptor 1 regulates glucose-stimulated insulin secretion (GSIS).
Topics: Acetates; ADP-Ribosylation Factor 6; ADP-Ribosylation Factors; Animals; cdc42 GTP-Binding Protein; Cell Line, Tumor; Cyclopropanes; Cysteine; Diabetes Mellitus, Type 2; Glucose; Insulin Secretion; Insulin-Secreting Cells; Leukotrienes; Mice; Neuropeptides; Quinolines; rac1 GTP-Binding Protein; Receptors, Leukotriene; Sulfides | 2018 |
Cysteinyl-leukotriene pathway as a new therapeutic target for the treatment of atherosclerosis related to obstructive sleep apnea syndrome.
Topics: 5-Lipoxygenase-Activating Proteins; Acetates; Adult; Animals; Arachidonate 5-Lipoxygenase; Atherosclerosis; Case-Control Studies; Cyclopropanes; Cysteine; Disease Models, Animal; Disease Progression; Female; Humans; Leukotriene Antagonists; Leukotriene E4; Leukotrienes; Male; Mice, Knockout, ApoE; Middle Aged; Plaque, Atherosclerotic; Quinolines; Receptors, Leukotriene; Risk Factors; Signal Transduction; Sleep Apnea, Obstructive; Sulfides | 2018 |
Cysteinyl Leukotriene Synthesis via Phospholipase A2 Group IV Mediates Exercise-induced Bronchoconstriction and Airway Remodeling.
Topics: Acetates; Airway Remodeling; Animals; Asthma; Bronchial Hyperreactivity; Bronchoconstriction; Cyclopropanes; Cysteine; Female; Group II Phospholipases A2; Leukotrienes; Lung; Methacholine Chloride; Mice; Mice, Inbred BALB C; Physical Conditioning, Animal; Quinolines; Respiratory Hypersensitivity; Sulfides | 2020 |
Targeting E. coli invasion of the blood-brain barrier for investigating the pathogenesis and therapeutic development of E. coli meningitis.
Topics: Acetates; Animals; Anti-Bacterial Agents; Blood-Brain Barrier; Brain; Ceftriaxone; Cells, Cultured; Cyclopropanes; Cysteine; Drug Therapy, Combination; Endothelial Cells; ErbB Receptors; Escherichia coli; Female; Gefitinib; Humans; Infant, Newborn; Leukotriene Antagonists; Leukotrienes; Male; Meningitis, Escherichia coli; Mice; Permeability; Phospholipases A2, Cytosolic; Quinolines; Sphingosine-1-Phosphate Receptors; Sulfides | 2020 |